INTRODUCTION
Repetitive exposure to various insults chronically increases the death rate of mature hepatocytes and triggers reparative responses to reconstitute damaged hepatic epithelium. Chronic liver injury is often accompanied by progressive liver fibrosis. 1 However, it is not fully understood why situations that cause chronic, but relatively incremental, increases in the rate of mature hepatocyte death typically result in some degree of hepatic architectural distortion and tend to promote liver fibrosis, when such outcomes rarely complicate recovery from acute injuries that abruptly cause massive hepatocyte loss. 2 In order to investigate regenerative mechanisms associated with chronically increased rates of hepatocyte death, we took advantage of mice with targeted disruption of the kinase that promotes nuclear accumulation of nuclear factor-kB (NF-kB), a transcription factor that controls expression of genes that encode hepatocyte viability factors. NF-kB is held in the cytoplasm in its inactive form by a specific inhibitor, inhibitor kB (IkB). The IkB kinase (Ikk) complex phosphorylates IkB, allowing NF-kB to translocate into the nucleus. 3 Ikk is comprised of three subunits, Ikka, Ikkb and Ikkg. Hepatocyte-specific deletion of Ikkb inhibits nuclear localisation of NF-kB, reduces expression of hepatocyte viability factors and increases hepatocyte susceptibility to apoptosis. 4e6 The present study evaluates the hypothesis that hepatocytes that are prone to apoptosis have an impaired proliferative capacity, but elaborate paracrine signals that trigger compensatory growth of
Significance of this study
What is already known about this subject?
< Disruption of the Ikkb kinase, and other factors that inhibit nuclear localisation of the prosurvival transcription factor NF-kB, promote the death of mature hepatocytes. < The death rate of hepatocytes is increased chronically in many types of chronic hepatitis, including non-alcoholic steatohepatitis (NASH). < Chronic efforts to regenerate dead hepatocytes are often associated with liver fibrosis. < Chronic regenerative responses also increase the risk of liver cancer.
What are the new findings?
< Dying hepatocytes generate Hedgehog (Hh) ligands, but are not Hh responsive themselves. < Hh ligands are viability factors for liver progenitors, and thus promote hepatic accumulation of cells that might contribute to cancer formation. < Hh ligands also promote hepatic accumulation of myofibroblasts, and thus increase fibrogenesis.
How might they impact on clinical practice in the foreseeable future?
< Non-invasive tests that detect/quantify Hh pathway activity might provide novel biomarkers of fibrogenesis and cancer risk in NASH. < Hh inhibitors might reduce development of cirrhosis and liver cancer by removing viability signals for myofibroblasts and immature liver cells.
progenitors which ultimately regenerate the hepatic parenchyma. Further, we theorise that this process also promotes hepatic fibrogenesis. Hedgehog (Hh) ligands activate a morphogenic signalling pathway that orchestrates tissue construction during development and adult wound healing. Because Hh pathway activity is low in healthy livers but high in various types of diseased livers, and Hh signalling promotes the growth of liver progenitors and myofibroblasts, 7 8 our aims were to determine if, and how, disrupting NF-kB survival signals in hepatocytes activates the Hh pathway in other liver cell types that are involved in fibrogenic repair of damaged livers. The results confirm our hypothesis and demonstrate an unsuspected mechanism that couples hepatocyte death to regenerative strategies that result in fibrogenic repair of liver damage. 
MATERIAL AND METHODS Experimental animals

Human subjects
Anomymised liver biopsy-proven non-alcoholic steatohepatitis (NASH) (n¼5) and NASH-related cirrhosis (n¼6) specimens were obtained from the Duke University, Division of Gastroenterology and Department of Pathology. The control liver tissues were obtained from the Duke University School of Medicine Tissue Bank Shared Resource and studied in accordance with NIH and Institutional guidelines for human subject research.
Liver histology and immunohistochemistry
Specimens fixed in formalin and embedded in paraffin were cut into 4 mm sections, dewaxed, hydrated, and subsequently incubated for 10 min in 3% hydrogen peroxide to block endogenous peroxidase. Antigen retrieval was performed by heating in 10 mM sodium citrate buffer (pH 6.0) for 10 min or incubation with 0.25% pepsin for 10 min. Sections were blocked in Dako protein block (X9090; Dako Envision, Dako, USA) for 30 min and incubated with primary antibodies, active capase 3 (9661, 1:250; Cell Signaling, Danvers, Massachusetts, USA), Ki67 (NCL-Ki67, 1:1000, Novocastra, Leica Microsystems, Newcastle Upon Tyne, UK), AE1/AE3 (18-0132, 1:500; Invitrogen, Carlsbad, California, USA), A6 (a gift from Dr Valentina Factor, National Institutes of Health, Bethesda, Maryland, USA), NF-kB p65 (ab7970, 1:5000; Abcam, Cambridge, Massachusetts, USA), Gli2 (26056, 1:4500; Abcam) and Sonic hedgehog (Shh; 1843-1, 1:7500; Epitomics, Burlingame, CA) at 48C overnight. Other sections were also incubated at 48C overnight in non-immune sera. Polymere horseradish peroxidase (HRP) antirabbit (K4003; Dako), antimouse (K4001; Dako) or MACH3 mouse AP polymer kit (MP530, Biocare Medical, Concord, California, USA) was used as secondary antibody. 3,3'-Diaminobenzidine (DAB) was employed in the detection procedure. Omitting primary antibodies from the reactions eliminated staining, demonstrating staining specificity.
Sirius red staining and AE1/AE3 and A6 immunohistochemical staining were assessed by morphometry (MetaView software, Universal Imaging Corp, Downington, Pennsylvania, USA). To quantify Sirius red staining, 10 randomly chosen 203 fields/section were evaluated for each mouse. The quantification of AE1/AE3 and A6 staining was evaluated by randomly choosing eight portal tracts (PTs) excluding the major bile duct, at 403 fields/section for each mouse. After excluding the major bile duct in each PT from consideration, cells staining positively for Ki67, p65 (cytosol or nuclear) or Gli2 (a Hh-regulated transcription factor) in eight PTs/slide were counted at 340 magnification. PTs selected for analysis contained a portal vein that ranged from 120 to 180 mm. The average number of Ki67-or Gli2-positive ductular cells was obtained by dividing the total number of positive cells by the total number of PTs. Ki67-, p65-or Gli2-positive hepatocytes were quantified by counting the total number of Ki67-, p65-or Gli-positive hepatocytes/field and dividing by the total number of hepatocytes/field.
RNA and protein analysis
Total RNA and protein were extracted from freeze-clamped liver samples that had been stored at À808C. A detailed protocol and the antibodies used are listed in the Supplementary Materials and methods. The sequences of primers for mice are summarised in Supplementary table 1.
Hepatic hydroxyproline assay
The hydroxyproline content in whole liver specimens was quantified colourimetrically as described in the Supplementary Materials and methods.
Isolation and study of primary liver cells from mice
Primary hepatocytes were obtained as described. 6 9 To isolate primary liver progenitors, we performed a two-step collagenase perfusion according to the protocol of Selgen et al, 10 and collected the non-parenchymal cell (NPC) fraction that contained progenitors using gradient centrifugation. Isolated cells were incubated with anti-Sca (stem cell antigen)-1 fluorescein isothiocyanate (FITC)-conjugated antibody (130-092-529 MACs, Miltenyi Biotec. GmbH, Bergisch Gladbach, Germany), followed by anti-FITC microbeads. After incubation, cells were positively selected using a MACS (magnetic-activated cell separation) sort. 11 12 As determined by trypan blue exclusion, cell viability was >90% in all experiments.
To evaluate apoptotic activity, hepatocytes and progenitors were cultured for 24 h and then cytocentrifuged to slides and examined for annexin V (ab14196, Abcam). For double immunofluorescent staining, cytospun cells were fixed, permeabilised, and processed for immunostaining with primary antibody annexin V and albumin (MAB1455, 1:100; R&D Systems, Minneapolis, Minnesota, USA). Alexa Fluor 568 and Alexa Fluor 488 (Molecular Probes, Eugene, Oregon, USA) were used as secondary antibodies. 4',6-Diamidino-2-phenylindole (DAPI) counterstaining was employed to demonstrate nuclei. Hepatocytes were also labelled with anti-mouse CD26 (559652, BD Biosciences, San Jose, California, USA) and annexin V (559933, BD Biosciences) or matched isotype control antisera, and analysed using the FACS VantageSe (Beckton Dickinson, Franklin Lakes, New Jersey, USA).
In separate experiments other freshly isolated progenitors were seeded in 96-well tissue culture plates (2000 cells/well) and grown in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% fetal bovine serum (FBS). After 72 h, the medium was replaced with 1% FBS IMDM; the next morning cells were treated with either cyclopamine (3 mM, Toronto Research Chemicals, North York, Ontario, Canada) or tomatidine (3 mM, Calbiochem, San Diego, California, USA) for 24 h. Control wells were treated with an equal volume of vehicle (dimethylsulfoxide (DMSO)) for the same treatment period. At the end of the treatment period, cell numbers were determined by Cell Counting Kit-8 (CCK-8, Dojindo, Rockvilee, Maryland, USA). A calibration curve was prepared using wells containing a fixed numbers of viable cells. A FLUOstar OPTIMA microplate reader (BMG Labtech, Durham, North Carolina, USA) was used for absorbance measurements.
Primary hepatocytes isolated from wild-type and Ikkb F/F mice (n¼5/group) were cultured in the presence of adenoviral vectors carrying green fluorescent protein (AdGFP) or Cre recombinanse (AdCre) (multiplicity of infection (MOI) 25). Cultures were analysed at 24 and 48 h.
Statistical analysis
Results are expressed as the mean6SEM. Significance was established using the Student t test and analysis of variance when appropriate. Differences were considered significant when p<0.05.
RESULTS
Ikkb
DHep mice have more apoptotic hepatocytes and increased liver progenitors
Although livers of Ikkb
DHep mice appeared grossly normal at baseline (Supplementary figure 1), they had increased caspase 3 activity by immunohistochemistry (IHC) (figure 1A, B) and western blot analysis ( figure 1C ). IHC of primary hepatocytes that were double-stained for annexin V, a marker of cells undergoing apoptosis, and albumin, a marker for hepatocytes, confirmed that many albumin-positive hepatocytes from Ikkb DHep mice were annexin V positive, whereas albumin-positive hepatocytes from Ikkb F/F mice were generally negative for annexin V ( figure 1D ). Fluorescence-activated cell sorting (FACS) analysis of primary hepatocytes which were double-stained for annexin V and CD26, another marker for mature hepatocytes, verified that more hepatocytes from Ikkb DHep mice were positive for annexin V ( figure 1E ). Hence, hepatocyte-specific deletion of Ikkb increased baseline hepatocyte apoptotic activity. As assessed by IHC, Ikkb F/F and Ikkb DHep mice exhibited dramatic differences in NF-kB localisation in response to liver injury. Strong nuclear localisation of NF-kB p65 was observed in MCDE-fed Ikkb F/F mice, whereas relatively few hepatocyte nuclei contained NF-kB p65 in MCDE-fed Ikkb DHep mice ( figure   3A , B). NF-kB p65 was localised predominantly in the cytosol of both hepatocytic and ductular cells in Ikkb DHep mice (figure 3A, B and Supplementary figure 2) . Therefore, after liver injury, Ikkb DHep mice had more NF-kB p65 in hepatocyte cytosol and less NF-kB p65 in hepatocyte nuclei than Ikkb F/F mice. To determine if these changes in NF-kB localisation were associated with differences in hepatocyte proliferative responses, liver sections from MCDE-fed Ikkb both at baseline and after liver injury ( figure 3D, E) . Because the ductular cell population is enriched with liver progenitors, 14 these findings suggested that hepatocyte-specific deletion of Ikkb promoted proliferation of liver progenitor populations.
Increased progenitors in Ikkb
DHep mice during liver damage figure 2A,  D) . Similarly, numbers of A6-positive progenitors were also greater in Ikkb
DHep mice than in Ikkb F/F mice ( figure 2A, E) . Therefore, hepatocyte-specific deletion of Ikkb promoted compensatory expansion of progenitor populations after liver injury.
Increased Hh signalling in Ikkb
DHep mice promotes progenitor viability figure 2) . This finding suggested that liver progenitors may not require nuclear localisation of NF-kB p65 to survive liver injury. In contrast, figure 5A,B) . Western blot analysis of protein lysates from Ikkb F/F hepatocytes that were treated with AdGFP or AdCre demonstrated that acute AdCre-mediated disruption of Ikkb led to caspase 3 activation and increased cellular production of both Shh and Ihh proteins ( figure 5C,D) . However, AdCre-treated hepatocytes did not exhibit increased expression of Hh target genes, such as Ptc or Gli2 (data not shown). Therefore, interrupting Ikkb function in isolated hepatocytes reduced their viability and induced them to produce Hh ligands that function as viability factors for liver progenitors.
Increased production of Hh ligands causes hepatic accumulation of Hh-responsive cells
Subsequent experiments used IHC for the Hh-regulated transcription factor Gli2, to identify which types of liver cells were Hh responsive in intact animals. Although few Gli2-positive cells were evident in the uninjured livers of either Ikkb F/F or Ikkb
DHep mice, quantitative analysis demonstrated that After only 1 week of diet-induced liver injury, the net numbers of Hh-responsive cells were about threefold greater in Ikkb DHep mice than in Ikkb F/F mice. Evidence that neither mature hepatocytes from Ikkb F/F mice nor hepatocytes from Ikkb DHep mice expressed Gli2 at baseline, and that targeted disruption of Ikkb function in cultured hepatocytes failed to activate expression of Hh-regulated genes suggested that the Gli2-positive hepatocytic cells in injured livers might have been derived from Hh-responsive progenitors that survived liver injury and then partially differentiated to replace dead hepatocytes. This concept was evaluated by double immunostaining liver sections for Gli2 and pancytokeratin, a marker of immature hepatocytes. 16 Co-localisation of Gli2 and pancytokeratin was demonstrated in hepatocytic cells, particularly periportally ( figure 6D ), supporting the possibility that Gli2-expressing hepatocytic cells in Ikkb DHep mice were immediate progeny of Gli2-positive progenitors that survived liver injury.
Enhanced fibrogenesis and liver fibrosis in Ikkb
DHep mice, and increased hepatocyte expression of Shh in patients with liver fibrosis Hepatocytes in healthy livers lack a basement membrane and, hence, are immediately adjacent to HSCs that reside in the space of Disse. Cells that produce Hh ligands release these factors in Figure 6 No Shh-positive hepatocytes were identified in healthy control livers (data not shown). In NASH livers, hepatocytes that stained for Shh were variably detected, with greater numbers of more strongly stained hepatocytes occurring in livers with more fibrosis ( figure 8AeC, Supplementary figure 3A,B) . Fibrotic NASH livers typically demonstrated foci of hepatocytes that were surrounded by stromal cells that expressed the myofibroblast marker, a-SMA. Double-immunostaining for Shh (brown) and a-SMA (blue) confirmed that a-SMA-positive myofibroblastic cells tended to localise near regions of Shhexpressing hepatocytes within the hepatic parenchyma ( figure  8D,E) . Thus, in NASH, a type of human liver disease in which there is increased hepatocyte apoptosis, increased hepatocyte expression of Hh ligands occurs, and this is accompanied by evidence of HSC activation and increased fibrogenesis.
DISCUSSION
Our results in Ikkb
DHep mice, a murine model of increased hepatocyte death, demonstrate that optimal viability and proliferative capacities of mature hepatocytes are heavily dependent upon an intact NF-kB pathway, whereas Hh signalling in liver progenitors provides an alternative survival mechanism that permits them to survive and proliferate even when NF-kB nuclear localisation is impaired. Moreover, we discovered that when the IkkbeNF-kB pathway is disrupted in mature hepatocytes, they produce Hh ligands. This enriches the hepatic microenvironment with factors that enhance the growth of Ikkb-deficient progenitor cells. As these progenitors mature, they eventually lose the ability to transduce Hh-initiated signals, and become more reliant on NF-kB-regulated viability factors. Thus, their vulnerability to apoptosis increases because IkkbeNF-kB signalling has been disrupted, and this perpetuates the increased rate of mature hepatocyte apoptosis. The latter maintains heightened production of Hh ligands and stimulates the continued outgrowth of Hh-responsive non-parenchymal cells that rely on Hh signalling to survive, including myofibroblasts. Progressive hepatic accumulation of such cells promotes fibrogenic repair, helping to explain why liver fibrosis is increased in Ikkb DHep mice.
Increased hepatocyte production of Hh ligands and accumulation of Hh target cells (ie, MF cells) were also demonstrated in patients with NASH. Increased rates of hepatocyte apoptosis are known to occur in this common type of chronic human liver disease. Moreover, hepatic apoptotic activity predicts the severity of liver fibrosis in NASH, and is significantly greater in patients with advanced fibrosis than in patients with early fibrosis.
20 MF-HSCs play major roles in excessive matrix accumulation during many types of chronic liver disease, including NASH. Earlier work showed that phagocytosis of apoptotic bodies activates quiescent HSCs (Q-HSCs) to become MFHSCs. 21 Therefore, the early stages of fibrosis in NASH are characterised by deposition of fibrous matrix around hepatocytes and along sinusoids. 22 The new evidence that injured hepatocytes in NASH produce Shh ligands provides another mechanism that helps to explain the pattern of liver fibrosis that occurs in NASH because HSCs are capable of responding to Hh ligands. In healthy livers, Q-HSCs produce relatively large amounts of Hip (Hh-interacting protein), a potent Hh ligand antagonist. However, HSC expression of Hip is abolished by liver injury (or culture), permitting Hh-dependent induction of MF genes and enhancing the viability and proliferative activity of MF-HSCs. 18 19 MF-HSCs themselves produce and release Hh ligands, 19 further enriching the hepatic microenvironment with these factors.
Mature Hh ligands diffuse away from the cells that produce them, and variably modulate gene expression in distant Hhresponsive cells. Target cell effects depend upon the concentration and duration of Hh ligand exposure. 23 Membranous particles containing biologically active Hh ligands have been purified from the blood and bile of experimental animals with liver injury, 17 suggesting routes by which Hh ligands generated by apoptotic hepatocytes and MF-HSCs might be disseminated both extrahepatically and to other parts of the liver lobule. Hepatic progenitors that reside in the canals of Hering and bile ductular cells in PTs are Hh responsive, and Hh ligands released from MFHSCs have been shown to enhance the viability and proliferative activity of both cell types. 24 This promotes the ductular response that often accompanies chronic liver injury. 24 25 Hh ligands also stimulate immature ductular cells to undergo epithelial to mesenchymal transition (EMT), 26 a process that may furher contribute to liver fibrosis. 26 Indeed, quantitiative reverse transcriptionePCR (RTePCR) analysis of liver RNA from Ikkb DHep mice demonstrated increased expression of various EMT-related factors (Supplementary figure 4) . Hence, evidence that dying hepatocytes release morphogens that trigger hepatic accumulation of cell types that mediate fibrogenic repair suggests a unifying mechanism that helps to explain the strong association between chronic liver injury and fibrogenesis. This discovery identifies novel diagnostic and therapeutic targets for further research that are relevant to various types of chronic liver injury.
